Instrumental evaluation of retinoid-induced skin irritation (Q31076317)

28 June 2017

Instrumental evaluation of retinoid-induced skin irritation (English)

1 reference

28 June 2017

Stücker M

1

1 reference

PubMed ID

12060479

28 June 2017

Hoffmann M

series ordinal

2

1 reference

PubMed ID

12060479

28 June 2017

Altmeyer P

series ordinal

3

1 reference

28 June 2017

1 May 2002

1 reference

Skin Research and Technology

28 June 2017

1 reference

28 June 2017

8

1 reference

28 June 2017

2

1 reference

28 June 2017

133-140

1 reference

[Systemic therapy of psoriasis]

28 June 2017

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0846.2002.00330.X

7 January 2021

Topical calcitriol in the treatment of chronic plaque psoriasis: a double-blind study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0846.2002.00330.X

7 January 2021

Response of psoriasis to a new topical retinoid, AGN 190168

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0846.2002.00330.X

7 January 2021

Tazarotene--first of a new generation of receptor-selective retinoids.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0846.2002.00330.X

7 January 2021

Early clinical development of tazarotene

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0846.2002.00330.X

7 January 2021

The pathogenesis of psoriasis and the mechanism of action of tazarotene

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0846.2002.00330.X

7 January 2021

Molecular mechanisms of tazarotene action in psoriasis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0846.2002.00330.X

7 January 2021

https://api.crossref.org/works/10.1034%2FJ.1600-0846.2002.00330.X

1 reference

7 January 2021

Once-daily tazarotene gel versus twice-daily fluocinonide cream in the treatment of plaque psoriasis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0846.2002.00330.X

7 January 2021

A pharmacoeconomic analysis of topical therapies for patients with mild-to-moderate stable plaque psoriasis: a US study.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0846.2002.00330.X

7 January 2021

Safety, efficacy and duration of therapeutic effect of tazarotene used in the treatment of plaque psoriasis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0846.2002.00330.X

7 January 2021

Pharmacokinetics and safety review of tazarotene

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0846.2002.00330.X

7 January 2021

Tazarotene: a review of its pharmacological profile and potential for clinical use in psoriasis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0846.2002.00330.X

7 January 2021

The Validity and Practicality of Sun-Reactive Skin Types I Through VI

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0846.2002.00330.X

7 January 2021

20 MHz sonography, colorimetry and image analysis in the evaluation of psoriasis vulgaris

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0846.2002.00330.X

7 January 2021

Two-dimensional blood flow determinations in allergic reactions using laser Doppler scanning

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0846.2002.00330.X

7 January 2021

Quantification of cutaneous pharmacological reactions: comparison of laser Doppler scanning, colorimetry, planimetry and skin temperature measurement

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0846.2002.00330.X

7 January 2021

Guidelines for transepidermal water loss (TEWL) measurement. A report from the Standardization Group of the European Society of Contact Dermatitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0846.2002.00330.X

7 January 2021

Guidelines on sodium lauryl sulfate (SLS) exposure tests. A report from the Standardization Group of the European Society of Contact Dermatitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0846.2002.00330.X

7 January 2021

Characterization of irritant patch test reactions to topical D vitamins and all-trans retinoic acid in comparison with sodium lauryl sulphate. Evaluation by clinical scoring and multiparametric non-invasive measuring techniques

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0846.2002.00330.X

7 January 2021

Optimising the use of tazarotene in clinical practice: consensus statement from the European advisory panel for tazarotene (Zorac TM)

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0846.2002.00330.X

7 January 2021

Combination therapy with tazarotene plus a topical corticosteroid for the treatment of plaque psoriasis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0846.2002.00330.X

7 January 2021

Tazarotene in combination with topical corticosteroids

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0846.2002.00330.X

7 January 2021

[Mometasone and calcipotriol optimize the initial therapeutic effect of dithranol in chronic persistent psoriasis]

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0846.2002.00330.X

7 January 2021

Tazarotene increases the antipsoriatic effect of dithranol in chronic psoriasis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0846.2002.00330.X

7 January 2021

Combination phototherapy of psoriasis with narrow-band UVB irradiation and topical tazarotene gel

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0846.2002.00330.X

7 January 2021

10.1034/J.1600-0846.2002.00330.X

Identifiers

DOI

1 reference

28 June 2017

1 reference

PubMed ID

12060479